Hong Kong's Department of Health said on September 29 that it plans to revise the Codes of Practice for licensed private healthcare facilities so that all injectable and infusible products used there must fall into one of three categories: pharmaceutical products registered or exempt from registration, human organ or tissue products compliant with the Human Organ Transplant Ordinance, or medical devices listed under the Medical Device Administrative Control System. The department said its Advisory Committee endorsed the updated requirements.

The department said it intends to publish the revised codes in the Gazette in the fourth quarter of 2026. Except for sections on medical devices, they would take effect one month after publication; the requirement on injectable and infusible medical devices listed under the system would take effect on March 1, 2027, to give facilities time to find compliant alternatives. The department said it wrote to licensees, licence applicants and the medical device industry on September 9, 2026.

The department said injection procedures are medical procedures that should only be performed by locally registered medical practitioners or registered dentists. It said it had issued more than 3,400 clinic licences or letters of exemption for small practice clinics as of September 28, and that it expects premises providing medical services, including those claiming to offer beauty services, to require a relevant licence or letter of exemption as early as the end of December 2027.